The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)

Detalles Bibliográficos
Autores principales: Leinonen, Mika, Hallén, Bengt, Olivecrona, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184312/
http://dx.doi.org/10.1186/1546-0096-12-S1-P76
_version_ 1782337824761053184
author Leinonen, Mika
Hallén, Bengt
Olivecrona, Hans
author_facet Leinonen, Mika
Hallén, Bengt
Olivecrona, Hans
author_sort Leinonen, Mika
collection PubMed
description
format Online
Article
Text
id pubmed-4184312
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41843122014-10-30 The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS) Leinonen, Mika Hallén, Bengt Olivecrona, Hans Pediatr Rheumatol Online J Poster Presentation BioMed Central 2014-09-17 /pmc/articles/PMC4184312/ http://dx.doi.org/10.1186/1546-0096-12-S1-P76 Text en Copyright © 2014 Leinonen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Leinonen, Mika
Hallén, Bengt
Olivecrona, Hans
The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
title The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
title_full The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
title_fullStr The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
title_full_unstemmed The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
title_short The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)
title_sort il-1 receptor antagonist anakinra (kineret®) stabilizes the nlrp3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (caps)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184312/
http://dx.doi.org/10.1186/1546-0096-12-S1-P76
work_keys_str_mv AT leinonenmika theil1receptorantagonistanakinrakineretstabilizesthenlrp3mutationspecificriskforhearinglossinpatientswithseverecryopyrinassociatedperiodicsyndromescaps
AT hallenbengt theil1receptorantagonistanakinrakineretstabilizesthenlrp3mutationspecificriskforhearinglossinpatientswithseverecryopyrinassociatedperiodicsyndromescaps
AT olivecronahans theil1receptorantagonistanakinrakineretstabilizesthenlrp3mutationspecificriskforhearinglossinpatientswithseverecryopyrinassociatedperiodicsyndromescaps
AT leinonenmika il1receptorantagonistanakinrakineretstabilizesthenlrp3mutationspecificriskforhearinglossinpatientswithseverecryopyrinassociatedperiodicsyndromescaps
AT hallenbengt il1receptorantagonistanakinrakineretstabilizesthenlrp3mutationspecificriskforhearinglossinpatientswithseverecryopyrinassociatedperiodicsyndromescaps
AT olivecronahans il1receptorantagonistanakinrakineretstabilizesthenlrp3mutationspecificriskforhearinglossinpatientswithseverecryopyrinassociatedperiodicsyndromescaps

Ejemplares similares